MangoGen Pharma is a biotech company with a mission to develop novel approaches to deliver specific genes to promote and accelerate wound healing.
The MangoGen team is dedicated to developing and producing a novel gene-delivering stent, gene-delivering film-dressings and gene-delivering sutures.
If you are interested in investment opportunities, please contact:
Paul Plested, CEO
For recent news about MangoGen go to: